<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2018-01-31" version="189">
<accession>P51617</accession>
<accession>D3DWW3</accession>
<accession>D3DWW4</accession>
<accession>Q7Z5V4</accession>
<accession>Q96C06</accession>
<accession>Q96RL2</accession>
<name>IRAK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interleukin-1 receptor-associated kinase 1</fullName>
<shortName>IRAK-1</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">IRAK1</name>
<name type="synonym">IRAK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Science" volume="271" first="1128" last="1131">
<title>IRAK: a kinase associated with the interleukin-1 receptor.</title>
<authorList>
<person name="Cao Z."/>
<person name="Henzel W.J."/>
<person name="Gao X."/>
</authorList>
<dbReference type="PubMed" id="8599092"/>
<dbReference type="DOI" id="10.1126/science.271.5252.1128"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>VARIANTS SER-196 AND LEU-532</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mamm. Genome" volume="11" first="182" last="190">
<title>Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions.</title>
<authorList>
<person name="Reichwald K."/>
<person name="Thiesen J."/>
<person name="Wiehe T."/>
<person name="Weitzel J."/>
<person name="Poustka W.A."/>
<person name="Rosenthal A."/>
<person name="Platzer M."/>
<person name="Stratling W.H."/>
<person name="Kioschis P."/>
</authorList>
<dbReference type="PubMed" id="10723722"/>
<dbReference type="DOI" id="10.1007/s003350010035"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="29037" last="29044">
<title>IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="11397809"/>
<dbReference type="DOI" id="10.1074/jbc.M103815200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="6521" last="6532">
<title>A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.</title>
<authorList>
<person name="Rao N."/>
<person name="Nguyen S."/>
<person name="Ngo K."/>
<person name="Fung-Leung W.P."/>
</authorList>
<dbReference type="PubMed" id="16024789"/>
<dbReference type="DOI" id="10.1128/MCB.25.15.6521-6532.2005"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1997" name="Immunity" volume="7" first="837" last="847">
<title>MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.</title>
<authorList>
<person name="Wesche H."/>
<person name="Henzel W.J."/>
<person name="Shillinglaw W."/>
<person name="Li S."/>
<person name="Cao Z."/>
</authorList>
<dbReference type="PubMed" id="9430229"/>
<dbReference type="DOI" id="10.1016/S1074-7613(00)80402-1"/>
</citation>
<scope>INTERACTION WITH MYD88</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="346" last="351">
<title>Tollip, a new component of the IL-1R1 pathway, links IRAK to the IL-1 receptor.</title>
<authorList>
<person name="Burns K."/>
<person name="Clatworthy J."/>
<person name="Martin L."/>
<person name="Martinon F."/>
<person name="Plumpton C."/>
<person name="Maschera B."/>
<person name="Lewis A."/>
<person name="Ray K."/>
<person name="Tschopp J."/>
<person name="Volpe F."/>
</authorList>
<dbReference type="PubMed" id="10854325"/>
<dbReference type="DOI" id="10.1038/35014038"/>
</citation>
<scope>INTERACTION WITH TOLLIP</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5567" last="5572">
<title>IRAK4: a novel member of the IRAK family with the properties of an IRAK-kinase.</title>
<authorList>
<person name="Li S."/>
<person name="Strelow A."/>
<person name="Fontana E.J."/>
<person name="Wesche H."/>
</authorList>
<dbReference type="PubMed" id="11960013"/>
<dbReference type="DOI" id="10.1073/pnas.082100399"/>
</citation>
<scope>INTERACTION WITH IRAK4</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="10952" last="10956">
<title>Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.</title>
<authorList>
<person name="Jiang Z."/>
<person name="Johnson H.J."/>
<person name="Nie H."/>
<person name="Qin J."/>
<person name="Bird T.A."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="12496252"/>
<dbReference type="DOI" id="10.1074/jbc.M212112200"/>
</citation>
<scope>INTERACTION WITH PELI1 AND TRAF6</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="FEBS Lett." volume="547" first="157" last="161">
<title>Characterization of Pellino2, a substrate of IRAK1 and IRAK4.</title>
<authorList>
<person name="Strelow A."/>
<person name="Kollewe C."/>
<person name="Wesche H."/>
</authorList>
<dbReference type="PubMed" id="12860405"/>
<dbReference type="DOI" id="10.1016/S0014-5793(03)00697-5"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PELI2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="197" first="263" last="268">
<title>Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.</title>
<authorList>
<person name="Burns K."/>
<person name="Janssens S."/>
<person name="Brissoni B."/>
<person name="Olivos N."/>
<person name="Beyaert R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="12538665"/>
<dbReference type="DOI" id="10.1084/jem.20021790"/>
</citation>
<scope>PHOSPHORYLATION BY IRAK4</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Immunol." volume="171" first="1500" last="1506">
<title>Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="12874243"/>
<dbReference type="DOI" id="10.4049/jimmunol.171.3.1500"/>
</citation>
<scope>INTERACTION WITH PELI3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="4161" last="4165">
<title>Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase C.</title>
<authorList>
<person name="Mamidipudi V."/>
<person name="Lin C."/>
<person name="Seibenhener M.L."/>
<person name="Wooten M.W."/>
</authorList>
<dbReference type="PubMed" id="14684752"/>
<dbReference type="DOI" id="10.1074/jbc.C300431200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-66</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="5227" last="5236">
<title>Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling.</title>
<authorList>
<person name="Kollewe C."/>
<person name="Mackensen A.C."/>
<person name="Neumann D."/>
<person name="Knop J."/>
<person name="Cao P."/>
<person name="Li S."/>
<person name="Wesche H."/>
<person name="Martin M.U."/>
</authorList>
<dbReference type="PubMed" id="14625308"/>
<dbReference type="DOI" id="10.1074/jbc.M309251200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-209 AND THR-387</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF THR-209 AND THR-387</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="26748" last="26753">
<title>IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness.</title>
<authorList>
<person name="Qin J."/>
<person name="Jiang Z."/>
<person name="Qian Y."/>
<person name="Casanova J.-L."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="15084582"/>
<dbReference type="DOI" id="10.1074/jbc.M400785200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-239</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51697" last="51703">
<title>IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression.</title>
<authorList>
<person name="Huang Y."/>
<person name="Li T."/>
<person name="Sane D.C."/>
<person name="Li L."/>
</authorList>
<dbReference type="PubMed" id="15465816"/>
<dbReference type="DOI" id="10.1074/jbc.M410369200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF STAT3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Immunity" volume="23" first="479" last="490">
<title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST 2 and induces T helper type 2-associated cytokines.</title>
<authorList>
<person name="Schmitz J."/>
<person name="Owyang A."/>
<person name="Oldham E."/>
<person name="Song Y."/>
<person name="Murphy E."/>
<person name="McClanahan T.K."/>
<person name="Zurawski G."/>
<person name="Moshrefi M."/>
<person name="Qin J."/>
<person name="Li X."/>
<person name="Gorman D.M."/>
<person name="Bazan J.F."/>
<person name="Kastelein R.A."/>
</authorList>
<dbReference type="PubMed" id="16286016"/>
<dbReference type="DOI" id="10.1016/j.immuni.2005.09.015"/>
</citation>
<scope>INTERACTION WITH IL1RL1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="J. Exp. Med." volume="201" first="915" last="923">
<title>Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.</title>
<authorList>
<person name="Uematsu S."/>
<person name="Sato S."/>
<person name="Yamamoto M."/>
<person name="Hirotani T."/>
<person name="Kato H."/>
<person name="Takeshita F."/>
<person name="Matsuda M."/>
<person name="Coban C."/>
<person name="Ishii K.J."/>
<person name="Kawai T."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="15767370"/>
<dbReference type="DOI" id="10.1084/jem.20042372"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF IRF7</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="1057" last="1065">
<title>Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1.</title>
<authorList>
<person name="Choi K.C."/>
<person name="Lee Y.S."/>
<person name="Lim S."/>
<person name="Choi H.K."/>
<person name="Lee C.H."/>
<person name="Lee E.K."/>
<person name="Hong S."/>
<person name="Kim I.H."/>
<person name="Kim S.J."/>
<person name="Park S.H."/>
</authorList>
<dbReference type="PubMed" id="16951688"/>
<dbReference type="DOI" id="10.1038/ni1383"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH IRAK4; MYD88; PELI1 AND TRAF6</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Mol. Immunol." volume="44" first="900" last="905">
<title>Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants.</title>
<authorList>
<person name="Su J."/>
<person name="Richter K."/>
<person name="Zhang C."/>
<person name="Gu Q."/>
<person name="Li L."/>
</authorList>
<dbReference type="PubMed" id="16690127"/>
<dbReference type="DOI" id="10.1016/j.molimm.2006.03.021"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Biochem. J." volume="409" first="43" last="52">
<title>The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1.</title>
<authorList>
<person name="Ordureau A."/>
<person name="Smith H."/>
<person name="Windheim M."/>
<person name="Peggie M."/>
<person name="Carrick E."/>
<person name="Morrice N."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="17997719"/>
<dbReference type="DOI" id="10.1042/BJ20071365"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PELI1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="3538" last="3547">
<title>Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.</title>
<authorList>
<person name="Conze D.B."/>
<person name="Wu C.J."/>
<person name="Thomas J.A."/>
<person name="Landstrom A."/>
<person name="Ashwell J.D."/>
</authorList>
<dbReference type="PubMed" id="18347055"/>
<dbReference type="DOI" id="10.1128/MCB.02098-07"/>
</citation>
<scope>UBIQUITINATION AT LYS-134 AND LYS-180 BY TRAF6</scope>
<scope>INTERACTION WITH IKBKG/NEMO</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Nature" volume="461" first="114" last="119">
<title>Direct activation of protein kinases by unanchored polyubiquitin chains.</title>
<authorList>
<person name="Xia Z.-P."/>
<person name="Sun L."/>
<person name="Chen X."/>
<person name="Pineda G."/>
<person name="Jiang X."/>
<person name="Adhikari A."/>
<person name="Zeng W."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="19675569"/>
<dbReference type="DOI" id="10.1038/nature08247"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="18276" last="18282">
<title>IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).</title>
<authorList>
<person name="Dunne A."/>
<person name="Carpenter S."/>
<person name="Brikos C."/>
<person name="Gray P."/>
<person name="Strelow A."/>
<person name="Wesche H."/>
<person name="Morrice N."/>
<person name="O'Neill L.A."/>
</authorList>
<dbReference type="PubMed" id="20400509"/>
<dbReference type="DOI" id="10.1074/jbc.M109.098137"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TIRAP</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="269" last="276">
<title>IRAK1: a critical signaling mediator of innate immunity.</title>
<authorList>
<person name="Gottipati S."/>
<person name="Rao N.L."/>
<person name="Fung-Leung W.P."/>
</authorList>
<dbReference type="PubMed" id="17890055"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2007.08.009"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Trends Immunol." volume="30" first="33" last="42">
<title>The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling.</title>
<authorList>
<person name="Moynagh P.N."/>
</authorList>
<dbReference type="PubMed" id="19022706"/>
<dbReference type="DOI" id="10.1016/j.it.2008.10.001"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371; SER-375 AND SER-556</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2017" name="J. Clin. Invest." volume="127" first="2192" last="2205">
<title>An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes.</title>
<authorList>
<person name="Yan J."/>
<person name="Hedl M."/>
<person name="Abraham C."/>
</authorList>
<dbReference type="PubMed" id="28436939"/>
<dbReference type="DOI" id="10.1172/JCI86282"/>
</citation>
<scope>INTERACTION WITH INAVA</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="J. Virol." volume="91">
<title>Mumps virus SH protein inhibits NF-kappaB activation by interacting with tumor necrosis factor receptor 1, interleukin-1 receptor 1, and Toll-like receptor 3 complexes.</title>
<authorList>
<person name="Franz S."/>
<person name="Rennert P."/>
<person name="Woznik M."/>
<person name="Gruetzke J."/>
<person name="Luedde A."/>
<person name="Arriero Pais E.M."/>
<person name="Finsterbusch T."/>
<person name="Geyer H."/>
<person name="Mankertz A."/>
<person name="Friedrich N."/>
</authorList>
<dbReference type="PubMed" id="28659487"/>
<dbReference type="DOI" id="10.1128/JVI.01037-17"/>
</citation>
<scope>INTERACTION WITH MUMPS VIRUS PROTEIN SH</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] MET-398; MET-412; HIS-421; LEU-532; SER-619; MET-625; TRP-638 AND GLY-690</scope>
</reference>
<comment type="function">
<text evidence="8 12 15 16 17 18 23 26">Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="subunit">
<text evidence="4 7 9 10 13 19 21 24 27 30">Homodimer (By similarity). Forms a complex with TRAF6, PELI1, IRAK4 and MYD88 (PubMed:16951688). Direct binding of SMAD6 to PELI1 prevents complex formation and hence negatively regulates IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression (PubMed:16951688). The TRAF6-PELI1-IRAK4-MYD88 complex recruits MAP3K7/TAK1, TAB1 and TAB2 to mediate NF-kappa-B activation (PubMed:16951688). Interaction with MYD88 recruits IRAK1 to the stimulated receptor complex (PubMed:9430229). Interacts with TOLLIP; this interaction occurs in the cytosol prior to receptor activation (PubMed:10854325). Interacts with IL1RL1 (PubMed:16286016). Interacts with PELI1 and TRAF6 (PubMed:12496252). Interacts (when polyubiquitinated) with IKBKG/NEMO (PubMed:18347055). Interacts with RSAD2/viperin (By similarity). Interacts with IRAK1BP1 (By similarity). Interacts with PELI2 (By similarity). Interacts with ZC3H12A; this interaction increases the interaction between ZC3H12A and IKBKB/IKKB (By similarity). Interacts with IRAK4 (PubMed:11960013). Interacts with PELI3 (PubMed:12874243). Interacts with INAVA; the interaction takes place upon PRR stimulation (PubMed:28436939).</text>
</comment>
<comment type="subunit">
<text evidence="28">(Microbial infection) Interacts with mumps virus protein SH; this interaction inhibits downstream NF-kappa-B pathway activation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-751345">
<id>Q15306</id>
<label>IRF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-968267">
<id>Q92985</id>
<label>IRF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-447677">
<id>Q99836</id>
<label>MYD88</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
<label>PELI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-448407">
<id>Q9HAT8</id>
<label>PELI2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-448472">
<id>Q8N2H9-2</id>
<label>PELI3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-528644">
<id>P58753</id>
<label>TIRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-2800345">
<id>Q86WV6</id>
<label>TMEM173</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-359276">
<id>Q9Y4K3</id>
<label>TRAF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-6116986">
<id>Q8VCW4</id>
<label>Unc93b1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358664"/>
<interactant intactId="EBI-5326026">
<id>Q5D1E7</id>
<label>Zc3h12a</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Lipid droplet</location>
</subcellularLocation>
<text evidence="3">Translocates to the nucleus when sumoylated. RSAD2/viperin recruits it to the lipid droplet (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P51617-1</id>
<name>1</name>
<name>a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P51617-2</id>
<name>2</name>
<name>b</name>
<sequence type="described" ref="VSP_011851"/>
<text>Inactive.</text>
</isoform>
<isoform>
<id>P51617-3</id>
<name>3</name>
<sequence type="described" ref="VSP_011849 VSP_011850 VSP_011851"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P51617-4</id>
<name>4</name>
<sequence type="described" ref="VSP_041950"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8">Isoform 1 and isoform 2 are ubiquitously expressed in all tissues examined, with isoform 1 being more strongly expressed than isoform 2.</text>
</comment>
<comment type="domain">
<text evidence="14">The ProST region is composed of many proline and serine residues (more than 20 of each) and some threonines. This region is the site of IRAK-1 hyperphosphorylation.</text>
</comment>
<comment type="PTM">
<text evidence="8 11 14 15">Following recruitment on the activated receptor complex, phosphorylated on Thr-209, probably by IRAK4, resulting in a conformational change of the kinase domain, allowing further phosphorylations to take place. Thr-387 phosphorylation in the activation loop is required to achieve full enzymatic activity.</text>
</comment>
<comment type="PTM">
<text evidence="20 24 25">Polyubiquitinated by TRAF6 after cell stimulation with IL-1-beta by PELI1, PELI2 and PELI3. Polyubiquitination occurs with polyubiquitin chains linked through 'Lys-63'. Ubiquitination promotes interaction with NEMO/IKBKG. Also sumoylated; leading to nuclear translocation.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. Pelle subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="L76191">
<property type="protein sequence ID" value="AAC41949.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF030876">
<property type="protein sequence ID" value="AAC08756.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF346607">
<property type="protein sequence ID" value="AAK62888.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ054788">
<property type="protein sequence ID" value="AAY88246.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U52112">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471172">
<property type="protein sequence ID" value="EAW72762.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471172">
<property type="protein sequence ID" value="EAW72763.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471172">
<property type="protein sequence ID" value="EAW72764.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471172">
<property type="protein sequence ID" value="EAW72765.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC054000">
<property type="protein sequence ID" value="AAH54000.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014963">
<property type="protein sequence ID" value="AAH14963.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14740.1">
<molecule id="P51617-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35443.1">
<molecule id="P51617-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35444.1">
<molecule id="P51617-2"/>
</dbReference>
<dbReference type="PIR" id="G02512">
<property type="entry name" value="G02512"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001020413.1">
<molecule id="P51617-2"/>
<property type="nucleotide sequence ID" value="NM_001025242.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001020414.1">
<molecule id="P51617-4"/>
<property type="nucleotide sequence ID" value="NM_001025243.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001560.2">
<molecule id="P51617-1"/>
<property type="nucleotide sequence ID" value="NM_001569.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.522819"/>
<dbReference type="PDB" id="6BFN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A/B=194-530"/>
</dbReference>
<dbReference type="PDBsum" id="6BFN"/>
<dbReference type="ProteinModelPortal" id="P51617"/>
<dbReference type="SMR" id="P51617"/>
<dbReference type="BioGrid" id="109863">
<property type="interactions" value="122"/>
</dbReference>
<dbReference type="CORUM" id="P51617"/>
<dbReference type="DIP" id="DIP-397N"/>
<dbReference type="ELM" id="P51617"/>
<dbReference type="IntAct" id="P51617">
<property type="interactions" value="78"/>
</dbReference>
<dbReference type="MINT" id="MINT-97088"/>
<dbReference type="STRING" id="9606.ENSP00000358997"/>
<dbReference type="BindingDB" id="P51617"/>
<dbReference type="ChEMBL" id="CHEMBL3357"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2042"/>
<dbReference type="iPTMnet" id="P51617"/>
<dbReference type="PhosphoSitePlus" id="P51617"/>
<dbReference type="BioMuta" id="IRAK1"/>
<dbReference type="DMDM" id="8928535"/>
<dbReference type="EPD" id="P51617"/>
<dbReference type="MaxQB" id="P51617"/>
<dbReference type="PaxDb" id="P51617"/>
<dbReference type="PeptideAtlas" id="P51617"/>
<dbReference type="PRIDE" id="P51617"/>
<dbReference type="DNASU" id="3654"/>
<dbReference type="Ensembl" id="ENST00000369974">
<molecule id="P51617-4"/>
<property type="protein sequence ID" value="ENSP00000358991"/>
<property type="gene ID" value="ENSG00000184216"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369980">
<molecule id="P51617-1"/>
<property type="protein sequence ID" value="ENSP00000358997"/>
<property type="gene ID" value="ENSG00000184216"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393687">
<molecule id="P51617-2"/>
<property type="protein sequence ID" value="ENSP00000377291"/>
<property type="gene ID" value="ENSG00000184216"/>
</dbReference>
<dbReference type="GeneID" id="3654"/>
<dbReference type="KEGG" id="hsa:3654"/>
<dbReference type="UCSC" id="uc004fjr.2">
<molecule id="P51617-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3654"/>
<dbReference type="DisGeNET" id="3654"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000184216.11"/>
<dbReference type="GeneCards" id="IRAK1"/>
<dbReference type="H-InvDB" id="HIX0017146"/>
<dbReference type="HGNC" id="HGNC:6112">
<property type="gene designation" value="IRAK1"/>
</dbReference>
<dbReference type="HPA" id="CAB004461"/>
<dbReference type="HPA" id="HPA054476"/>
<dbReference type="MalaCards" id="IRAK1"/>
<dbReference type="MIM" id="300283">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P51617"/>
<dbReference type="OpenTargets" id="ENSG00000184216"/>
<dbReference type="Orphanet" id="93552">
<property type="disease" value="Pediatric systemic lupus erythematosus"/>
</dbReference>
<dbReference type="Orphanet" id="536">
<property type="disease" value="Systemic lupus erythematosus"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29912"/>
<dbReference type="eggNOG" id="KOG1187">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063073"/>
<dbReference type="HOGENOM" id="HOG000015226"/>
<dbReference type="HOVERGEN" id="HBG052144"/>
<dbReference type="InParanoid" id="P51617"/>
<dbReference type="KO" id="K04730"/>
<dbReference type="OMA" id="GFYCLVY"/>
<dbReference type="OrthoDB" id="EOG091G0YKT"/>
<dbReference type="PhylomeDB" id="P51617"/>
<dbReference type="TreeFam" id="TF328924"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-166058">
<property type="pathway name" value="MyD88:Mal cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209543">
<property type="pathway name" value="p75NTR recruits signalling complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209560">
<property type="pathway name" value="NF-kB is activated and signals survival"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446652">
<property type="pathway name" value="Interleukin-1 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450302">
<property type="pathway name" value="activated TAK1 mediates p38 MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450321">
<property type="pathway name" value="JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937039">
<property type="pathway name" value="IRAK1 recruits IKK complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975110">
<property type="pathway name" value="TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975138">
<property type="pathway name" value="TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975144">
<property type="pathway name" value="IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975155">
<property type="pathway name" value="MyD88 dependent cascade initiated on endosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975871">
<property type="pathway name" value="MyD88 cascade initiated on plasma membrane"/>
</dbReference>
<dbReference type="SignaLink" id="P51617"/>
<dbReference type="SIGNOR" id="P51617"/>
<dbReference type="GeneWiki" id="IRAK1"/>
<dbReference type="GenomeRNAi" id="3654"/>
<dbReference type="PRO" id="PR:P51617"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000184216"/>
<dbReference type="CleanEx" id="HS_IRAK1"/>
<dbReference type="ExpressionAtlas" id="P51617">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P51617">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045323">
<property type="term" value="C:interleukin-1 receptor complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid droplet"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031072">
<property type="term" value="F:heat shock protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004704">
<property type="term" value="F:NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007250">
<property type="term" value="P:activation of NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034605">
<property type="term" value="P:cellular response to heat"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051259">
<property type="term" value="P:protein oligomerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001959">
<property type="term" value="P:regulation of cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034142">
<property type="term" value="P:toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034162">
<property type="term" value="P:toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007178">
<property type="term" value="P:transmembrane receptor protein serine/threonine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd08794">
<property type="entry name" value="Death_IRAK1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR035533">
<property type="entry name" value="Death_IRAK1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035536">
<property type="entry name" value="IRAK1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24419:SF1">
<property type="entry name" value="PTHR24419:SF1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0551">Lipid droplet</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Interleukin-1 receptor-associated kinase 1" id="PRO_0000086030">
<location>
<begin position="1"/>
<end position="712"/>
</location>
</feature>
<feature type="domain" description="Death">
<location>
<begin position="27"/>
<end position="106"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="5">
<location>
<begin position="212"/>
<end position="521"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="5">
<location>
<begin position="218"/>
<end position="226"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="5">
<location>
<begin position="342"/>
<end position="345"/>
</location>
</feature>
<feature type="region of interest" description="ProST region">
<location>
<begin position="110"/>
<end position="211"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="649"/>
<end position="655"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="688"/>
<end position="691"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="5 6">
<location>
<position position="340"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="239"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="5">
<location>
<position position="358"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC/PRKCI" evidence="15">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="131"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by IRAK4" evidence="35">
<location>
<position position="209"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="371"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="375"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="556"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="24">
<location>
<position position="134"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="24">
<location>
<position position="180"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_011849" evidence="32">
<original>F</original>
<variation>FGGWRRAAGGREARGLLAPTPDAPRPA</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_041950" evidence="32 33">
<location>
<begin position="435"/>
<end position="513"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_011850" evidence="32">
<location>
<begin position="478"/>
<end position="492"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_011851" evidence="31 32">
<location>
<begin position="513"/>
<end position="542"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11465830." id="VAR_051629">
<original>R</original>
<variation>H</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1059702." id="VAR_051630" evidence="29">
<original>F</original>
<variation>S</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10127175." id="VAR_051631">
<original>C</original>
<variation>S</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56340948." id="VAR_040573" evidence="22">
<original>T</original>
<variation>M</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_040574" evidence="22">
<original>V</original>
<variation>M</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast pleomorphic lobular carcinoma sample; somatic mutation." id="VAR_040575" evidence="22">
<original>Q</original>
<variation>H</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1059703." id="VAR_040576" evidence="22 29">
<original>S</original>
<variation>L</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34112487." id="VAR_040577" evidence="22">
<original>G</original>
<variation>S</variation>
<location>
<position position="619"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35638718." id="VAR_040578" evidence="22">
<original>T</original>
<variation>M</variation>
<location>
<position position="625"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56082801." id="VAR_040579" evidence="22">
<original>R</original>
<variation>W</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_040580" evidence="22">
<original>S</original>
<variation>G</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely abolishes auto-phosphorylation in the kinase domain." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="16">
<original>K</original>
<variation>S</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62406"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10854325"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11397809"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11960013"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12496252"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12538665"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12860405"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12874243"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14625308"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684752"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084582"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15465816"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15767370"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16286016"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16690127"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951688"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997719"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18347055"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19675569"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20400509"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28436939"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28659487"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8599092"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9430229"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11397809"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16024789"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14625308"/>
</source>
</evidence>
<sequence length="712" mass="76537" checksum="A7ADED75D3A3981D" modified="2000-12-01" version="2">
MAGGPGPGEPAAPGAQHFLYEVPPWVMCRFYKVMDALEPADWCQFAALIVRDQTELRLCE
RSGQRTASVLWPWINRNARVADLVHILTHLQLLRARDIITAWHPPAPLPSPGTTAPRPSS
IPAPAEAEAWSPRKLPSSASTFLSPAFPGSQTHSGPELGLVPSPASLWPPPPSPAPSSTK
PGPESSVSLLQGARPFPFCWPLCEISRGTHNFSEELKIGEGGFGCVYRAVMRNTVYAVKR
LKENADLEWTAVKQSFLTEVEQLSRFRHPNIVDFAGYCAQNGFYCLVYGFLPNGSLEDRL
HCQTQACPPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDIKSSNVLLDERLTPKLGDFG
LARFSRFAGSSPSQSSMVARTQTVRGTLAYLPEEYIKTGRLAVDTDTFSFGVVVLETLAG
QRAVKTHGARTKYLKDLVEEEAEEAGVALRSTQSTLQAGLAADAWAAPIAMQIYKKHLDP
RPGPCPPELGLGLGQLACCCLHRRAKRRPPMTQVYERLEKLQAVVAGVPGHSEAASCIPP
SPQENSYVSSTGRAHSGAAPWQPLAAPSGASAQAAEQLQRGPNQPVESDESLGGLSAALR
SWHLTPSCPLDPAPLREAGCPQGDTAGESSWGSGPGSRPTAVEGLALGSSASSSSEPPQI
IINPARQKMVQKLALYEDGALDSLQLLSSSSLPGLGLEQDRQGPEESDEFQS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>